Humira has been one of the world’s top selling drugs for more than two decades. But thanks to some new copycats — including one that is being sold at entrepreneur Mark Cuban’s online pharmacy — its reign could be coming to an end.
Humira is an injectable drug approved in 2002 that treats a range of illnesses, including Crohn’s disease and rheumatoid arthritis. The drug is popular with patients but has a list price of nearly $7,000 a month, according to GoodRx, a website that helps patients find discounts on pharmaceuticals.
Even with insurance, the drug, made by AbbVie, can be quite expensive.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
